BRANFORD, Conn., Feb. 12 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN) announced today that Timothy M. Shannon, M.D., President and Chief Executive Officer, will present at the BIO CEO & Investor Conference on Wednesday, February 13, 2008, at 3:30 p.m. Eastern Standard Time.
Access to a live webcast of the presentation will be available at http://www.curagen.com. A replay of the webcast will be accessible beginning one hour after the presentation and available on the Company's website until March 13, 2008.
CuraGen Corporation (Nasdaq: CRGN) is a dedicated clinical-stage
biopharmaceutical company developing diverse approaches for the treatment
of cancer including the histone deacetylase inhibitor, belinostat, and the
antibody-drug conjugate, CR011-vcMMAE. By leveraging drug development
strengths cultivated over the years, CuraGen expects to make a difference
by advancing its promising therapeutics to address the unmet medical needs
of cancer patients. CuraGen Corporation is headquartered in Branford,
Connecticut. For additional information please visit http://www.curagen.com.
Glenn Schulman, PharmD
Director of Investor Relations
|SOURCE CuraGen Corporation|
Copyright©2008 PR Newswire.
All rights reserved